Markku Kallajoki

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 6

Top Topics

Ulcerative Colitis

Ejection Fraction

Disease Activity

Top Venues

Scientific reports

Experimental dermatology

This page only lists publications with an associated author ORCID identifier.

Publications

Lauri Polari, Mervi Tenhami, Santeri Anttila, Terhi Helenius, Harry Kujari, Markku Kallajoki, Markku Voutilainen, Diana M Toivola
Colonocyte keratin 7 is expressed de novo in inflammatory bowel diseases and associated with pathological changes and drug-resistance. Scientific reports 12 (1) (2022)
Lauri Polari, Mervi Tenhami, Santeri Anttila, Terhi Helenius, Harry Kujari, Markku Kallajoki, Markku Voutilainen, Diana M Toivola
Colonocyte keratin 7 is expressed de novo in inflammatory bowel diseases and associated with pathological changes and drug-resistance. Scientific reports 12 (1) (2022)
Lauri Polari, Mervi Tenhami, Santeri Anttila, Terhi Helenius, Harry Kujari, Markku Kallajoki, Markku Voutilainen, Diana M Toivola
Colonocyte keratin 7 is expressed de novo in inflammatory bowel diseases and associated with pathological changes and drug-resistance. Scientific reports 12 (1) (2022)
Lauri Polari, Mervi Tenhami, Santeri Anttila, Terhi Helenius, Harry Kujari, Markku Kallajoki, Markku Voutilainen, Diana M Toivola
Colonocyte keratin 7 is expressed de novo in inflammatory bowel diseases and associated with pathological changes and drug-resistance. Scientific reports 12 (1) (2022)
Lauri Polari, Mervi Tenhami, Santeri Anttila, Terhi Helenius, Harry Kujari, Markku Kallajoki, Markku Voutilainen, Diana M Toivola
Colonocyte keratin 7 is expressed de novo in inflammatory bowel diseases and associated with pathological changes and drug-resistance. Scientific reports 12 (1) (2022)
Pegah Rahmati Nezhad, Pilvi Riihilä, Minna Piipponen, Markku Kallajoki, Seppo K Meri, Liisa Nissinen, Veli-Matti Kähäri
Complement factor I upregulates expression of matrix metalloproteinase-13 and -2 and promotes invasion of cutaneous squamous carcinoma cells. Experimental dermatology 30 (11) (2021)